Company: EVLVW
Filing Date: 2025-11-13
Form Type: 10-Q
Source: 0001805385-25-000017
Chunk: 180

Company: Evolv Technologies Holdings, Inc.
Filing Date: 2025-11-13
Form: 10-Q
Item: Part I, Item 1
Chunk 180
---
570 — 3,670 — — 3,670 Stock-based compensation cost— — 5,664 — — 5,664 Cumulative translation adjustment— — — 26 — 26 Net loss— — — — (1,796)(1,796)Balances at September 30, 2025173,803,265 $17 $501,040 $(137)$(398,684)$102,236 

F-3

Common StockAdditionalPaid-inCapitalAccumulated Other Comprehensive Income (Loss)AccumulatedDeficitTotalStockholders’EquitySharesAmountBalances at December 31, 2023151,310,080 $15 $444,825 $(53)$(300,647)$144,140 Issuance of common stock upon net exercise of stock options519,089 1 301 — — 302 Issuance of common stock upon vesting of restricted stock units3,527,778 — — — — — Stock-based compensation cost— — 6,605 — — 6,605 Cumulative translation adjustment— — — 3 — 3 Net loss— — — — (11,272)(11,272)Balances at March 31, 2024155,356,947 $16 $451,731 $(50)$(311,919)$139,778 Issuance of common stock upon net exercise of stock options823,047 — 335 — — 335 Issuance of common stock upon vesting of restricted stock units1,294,128 — — — — — Stock-based compensation cost— — 7,679 — — 7,679 Cumulative translation adjustment— — — 8 — 8 Net income— — — — 3,418 3,418 Balances at June 30, 2024157,474,122 $16 $459,745 $(42)$(308,501)$151,218 Issuance of common stock upon net exercise of stock options659,000 — 515 — — 515 Issuance of common stock upon vesting of restricted stock units155,624 —